Cancer from an Unknown Primary Site
- 1 July 2003
- journal article
- review article
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 326 (1) , 35-46
- https://doi.org/10.1097/00000441-200307000-00006
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Gemcitabine, Carboplatin, and Paclitaxel for Patients With Carcinoma of Unknown Primary Site: A Minnie Pearl Cancer Research Network StudyJournal of Clinical Oncology, 2002
- Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2002
- Feasibility of Breast Preservation in the Treatment of Occult Primary Carcinoma Presenting With Axillary MetastasesAnnals of Surgical Oncology, 2001
- Treatable Subsets in Cancer of Unknown Primary OriginJapanese Journal of Cancer Research, 2001
- Two Sequential Studies for Primary Peritoneal Carcinoma: Induction with Weekly Cisplatin Followed by either Cisplatin–Doxorubicin–Cyclophosphamide or Paclitaxel–CisplatinGynecologic Oncology, 1997
- Unknown primary carcinoma: Randomised studies are needed to identify optimal treatments and their benefitsEuropean Journal Of Cancer, 1996
- The value of immunohistochemistry in patients with poorly differentiated adenocarcinomas and undifferentiated carcinomas of unknown primaryZeitschrift für Krebsforschung und Klinische Onkologie, 1996
- Evaluation of six tumor markers in patients with carcinoma of unknown primaryMedical and Pediatric Oncology, 1994
- Metastatic inguinal nodes from an unknown primary neoplasm. A review of 56 casesCancer, 1987
- Metastatic Adenocarcinomas of Unknown Primary SiteNew England Journal of Medicine, 1980